CA
NZ
UK
AU
IND
US
This is a results preview, not a results report: no second quarter figures were available at the time of writing, and the calendar gave no time for the release. Electra is building a cobalt sulfate refinery at Temiskaming Shores, Ontario, aimed at supplying battery …
INVO Fertility (NASDAQ:IVF), an operator of fertility clinics and a provider of an intravaginal culture device for in vitro fertilisation, traded at USD 0.5359, down 5.98%, in pre-market trading on Tuesday, October 27, 2026. No company-specific announcement dated on or just before Tuesday, October …
Zedge reported results for the fourth quarter and fiscal year ended July 31, 2026 on October 26, 2026. Fourth quarter GAAP net income was USD 0.4 million, or USD 0.03 per share, against a loss of USD 0.6 million a year earlier, and non-GAAP …
DataMeds AI (NASDAQ:MEDS), formerly Wellgistics Health, an integrated healthcare company combining pharmacy services, telemedicine and artificial intelligence platforms, traded at USD 2.06, down 5.76%, in pre-market trading on Tuesday, October 27, 2026. The most recent company-specific news was an announcement dated Thursday, October 22, …
This is a no-catalyst piece and results preview, not a results report: no reported figures for the second half of 2026 were available at the time of writing, and another data provider estimated the next report for November 17, 2026. Texxon Holding operates through …
CBAK Energy Technology (NASDAQ:CBAT), a maker of lithium-ion cells and battery materials with operations in Dalian and Nanjing, traded at USD 0.79, down 5.74%, in pre-market trading on Tuesday, October 27, 2026, according to the pre-market snapshot. No company-specific announcement dated on or just …
City Holding, a West Virginia bank holding company, earned USD 34.6 million in the third quarter, against USD 33.3 million in the second quarter and USD 35.2 million a year earlier. Diluted EPS of USD 2.43 was a record, and nine-month EPS was USD …
Moderna (NASDAQ:MRNA) and Merck reported Phase 3 results from the INTerpath-001 trial of an individualized neoantigen therapy, a personalized cancer vaccine, in melanoma. The trial showed a recurrence-free survival hazard ratio of 0.58 and a distant metastasis-free survival hazard ratio of 0.62. The company …
Telomir Pharmaceuticals (NASDAQ:TELO), a clinical-stage company developing Telomir-Zn, an investigational compound targeting metal-dependent disease pathways, traded at USD 1.0500, up 5.16%, in pre-market trading on Tuesday, October 27, 2026, according to a pre-market snapshot. No company-specific announcement dated on or just before Tuesday, October …
German American Bancorp, an Indiana bank holding company, earned a record USD 38.6 million against USD 35.1 million a year earlier, lifting EPS about 10% to USD 1.03. Net interest income was USD 83.5 million, up about 3% from the second quarter and about …
Please wait processing your request...